AIM
IDXX icon

Acrospire Investment Management’s Idexx Laboratories IDXX Stock Holding History

Acrospire Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-639
Closed -$103K – 688
2017
Q2 		$103K Sell
639
-202
-24% -$32.8K 0.1% 230
2017
Q1 		$130K Buy
841
+700
+496% +$96.5K 0.11% 174
2016
Q4 		$17K Sell
141
-2,159
-94% -$246K 0.01% 1816
2016
Q3 		$259K Buy
2,300
+1,600
+229% +$169K 0.17% 48
2016
Q2 		$65K Buy
700
+400
+133% +$34.4K 0.05% 843
2016
Q1 		$23K Buy
+300
New +$21.6K 0.02% 1471

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Acrospire Investment Management's IDXX Position: Q3 2017 in Review

Acrospire Investment Management sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 639 shares — an estimated $103K sold.

Acrospire Investment Management first reported a position in IDXX in Q1 2016 and held it in 6 quarters. The position peaked at $259K in Q3 2016. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • Acrospire Investment Management reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 639 Idexx Laboratories shares in Q3 2017, an estimated $103K.
  • Acrospire Investment Management first reported a position in Idexx Laboratories in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Idexx Laboratories position peaked at $259K in Q3 2016.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.